News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,067 Results
Type
Article (40717)
Company Profile (250)
Press Release (666099)
Multimedia
Podcasts (68)
Webinars (14)
Section
Business (204712)
Career Advice (2071)
Deals (35546)
Drug Delivery (98)
Drug Development (81534)
Employer Resources (172)
FDA (16322)
Job Trends (14932)
News (346510)
Policy (32700)
Tag
Academia (2581)
Accelerated approval (9)
Adcomms (24)
Allergies (96)
Alliances (49787)
ALS (108)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (160)
Approvals (16315)
Artificial intelligence (311)
Autoimmune disease (28)
Automation (18)
Bankruptcy (364)
Best Places to Work (11663)
BIOSECURE Act (19)
Biosimilars (120)
Biotechnology (175)
Bladder cancer (95)
Brain cancer (35)
Breast cancer (368)
Cancer (2885)
Cardiovascular disease (212)
Career advice (1733)
Career pathing (30)
CAR-T (183)
CDC (31)
Cell therapy (497)
Cervical cancer (24)
Clinical research (67151)
Collaboration (1019)
Company closure (3)
Compensation (680)
Complete response letters (21)
COVID-19 (2637)
CRISPR (58)
C-suite (322)
Cystic fibrosis (111)
Data (2980)
Decentralized trials (2)
Denatured (20)
Depression (58)
Diabetes (348)
Diagnostics (6434)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (135)
Drug pricing (121)
Drug shortages (29)
Duchenne muscular dystrophy (124)
Earnings (87474)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113926)
Executive appointments (847)
FDA (17963)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (927)
Gene editing (131)
Generative AI (23)
Gene therapy (372)
GLP-1 (783)
Government (4525)
Grass and pollen (4)
Guidances (181)
Healthcare (18896)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (151)
Immuno-oncology (10)
Indications (39)
Infectious disease (2808)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (331)
IPO (16606)
IRA (45)
Job creations (3655)
Job search strategy (1460)
Kidney cancer (13)
Labor market (52)
Layoffs (491)
Leadership (18)
Legal (7956)
Liver cancer (81)
Lung cancer (404)
Lymphoma (210)
Machine learning (11)
Management (58)
Manufacturing (383)
MASH (90)
Medical device (13486)
Medtech (13491)
Mergers & acquisitions (19654)
Metabolic disorders (852)
Multiple sclerosis (98)
NASH (17)
Neurodegenerative disease (115)
Neuropsychiatric disorders (32)
Neuroscience (2121)
NextGen: Class of 2025 (6544)
Non-profit (4503)
Now hiring (47)
Obesity (426)
Opinion (230)
Ovarian cancer (101)
Pain (104)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (299)
Patient recruitment (161)
Peanut (51)
People (57789)
Pharmaceutical (64)
Pharmacy benefit managers (21)
Phase I (20880)
Phase II (29555)
Phase III (22066)
Pipeline (1626)
Policy (200)
Postmarket research (2589)
Preclinical (8880)
Press Release (64)
Prostate cancer (141)
Psychedelics (37)
Radiopharmaceuticals (253)
Rare diseases (458)
Real estate (5932)
Recruiting (66)
Regulatory (22686)
Reports (50)
Research institute (2338)
Resumes & cover letters (357)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (87)
Series A (155)
Series B (106)
Service/supplier (11)
Sickle cell disease (61)
Special edition (19)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3598)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (57)
The Weekly (46)
Vaccines (785)
Venture capital (54)
Weight loss (259)
Women's health (45)
Worklife (18)
Date
Last 7 days (365)
Last 30 days (1771)
Last 365 days (31269)
2025 (16667)
2024 (35311)
2023 (40147)
2022 (51282)
2021 (55826)
2020 (54204)
2019 (46710)
2018 (35159)
2017 (32213)
2016 (31626)
2015 (37651)
2014 (31431)
2013 (26463)
2012 (28689)
2011 (29384)
2010 (27459)
Location
Africa (731)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38393)
Australia (6263)
California (7406)
Canada (2350)
China (677)
Colorado (321)
Connecticut (316)
Delaware (192)
Europe (82681)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (60)
Illinois (638)
India (27)
Indiana (360)
Iowa (16)
Japan (226)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1020)
Massachusetts (5510)
Michigan (245)
Minnesota (448)
Mississippi (3)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (80)
New Hampshire (67)
New Jersey (2067)
New Mexico (28)
New York (2082)
North Carolina (1078)
North Dakota (8)
Northern California (3260)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1608)
Puerto Rico (17)
Rhode Island (36)
South America (1106)
South Carolina (34)
South Dakota (1)
Southern California (2764)
Tennessee (125)
Texas (1116)
United States (27482)
Utah (219)
Virginia (182)
Washington D.C. (72)
Washington State (633)
West Virginia (4)
Wisconsin (65)
707,067 Results for "simulations plus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Simulations Plus Releases ADMET Predictor® 13
June 5, 2025
·
4 min read
Press Releases
Simulations Plus Releases DILIsym® 11
May 15, 2025
·
4 min read
Press Releases
Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum
June 12, 2025
·
1 min read
Press Releases
Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call
June 18, 2025
·
5 min read
Press Releases
Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results
April 4, 2025
·
15 min read
Press Releases
Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies
April 21, 2025
·
9 min read
Business
Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report third quarter fiscal 2024 financial results after the market close on Tuesday, July 2, 2024.
June 18, 2024
·
2 min read
Press Releases
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
February 4, 2025
·
3 min read
Press Releases
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
March 10, 2025
·
1 min read
Press Releases
Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date
March 20, 2025
·
2 min read
1 of 70,707
Next
